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Abstract
Background Postpartum haemorrhage is a leading cause of death in low-income and middle-income countries, but it 
is also largely preventable. As a potential solution for restoring blood volume in women with life-threatening 
haemorrhage in low-resource settings, a vaginal blood collection drape with adaptations for autotransfusion has been 
created. In this study, we aimed to assess the ﬁ ltration function of the autotransfusion system prototype and to 
determine the degree to which the ﬁ lter removes surrogate markers for amniotic ﬂ uid, fetal cells, and inhibin A, as 
well as to quantify the reduction of bacterial contaminants in postpartum blood after vaginal delivery. 
Methods We collected postpartum blood from four women who had normal spontaneous vaginal delivery of a term 
pregnancy using an adapted obstetrical blood collection drape. Immediately after the delivery, the research drape was 
placed under the buttocks of the participant and postpartum blood was collected. The blood entered a sterile system 
and was ﬁ ltered through a Pall LeukoGuard BC2 Cardioplegia ﬁ lter via a negative pressure pump. We tested 
preﬁ ltration and post-ﬁ ltration samples for the presence of fetal cells, inhibin A, and surrogate markers for amniotic 
ﬂ uid contamination. Cultures of preﬁ ltered and post-ﬁ ltered blood underwent qualitative analysis, to identify speciﬁ c 
bacterial species present, and quantitative analysis. 
Findings We identiﬁ ed Escherichia coli, Bacteroides fragilis, Klebsiella pneumoniae, Enterococcus faecalis, 
Corynebacterium jeikeium, Lactobacillus spp, and Staphylococcus spp in preﬁ ltration blood samples. In samples from 
three of the four participants, bacterial load decreased after ﬁ ltration. However, complete elimination of a bacterial 
species did not occur in two participants’ post-ﬁ lter cultures. Fetal cells were present in one preﬁ ltration sample and 
decreased but remained present after ﬁ ltration. Reduction in α-fetoprotein and inhibin A varied between the four 
participants’ post-ﬁ ltration samples.
Interpretation The ﬁ lter tested in the autotransfusion system prototype did not signiﬁ cantly reduce the surrogate 
markers tested nor eliminate bacteria in the four samples, although selective removal of Staphylococcus spp might 
have occurred. The system remains a promising solution to improve health outcomes of women who give birth in 
low-resource settings but improved ﬁ lter function does need to be addressed. Future studies will test a leucocyte 
depletion ﬁ lter, previously shown to successfully remove bacterial contaminants, as well as alter device ﬂ ow rates for 
optimum ﬁ lter function.
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